M.A. KRIKKER, M.D.
To the editor: On 7 June 1982, The Hemochromatosis Research Foundation, Inc. was founded for the following purposes:
1. To increase the awareness of the practicing physician that hereditary hemochromatosis is a disorder rarely diagnosed before clinically apparent (1). Hereditary hemochromatosis is distinguished from transfusional iron-overload resulting from the treatment of chronic hematologic disorders. Recent studies show that hereditary hemochromatosis is transmitted as an autosomal recessive disorder (2, 3). The incidence of heterozygosity for the hemochromatosis allele in the white population is approximately 10%. The expected incidence of homozygosity is about 2 to 3 per 1000 (1-3), an estimate supported
KRIKKER M. A Foundation for Hemochromatosis. Ann Intern Med. ;97:782. doi: 10.7326/0003-4819-97-5-782_3
Download citation file:
Published: Ann Intern Med. 1982;97(5):782.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use